Skip to main content
Glama

Mydisease

by io.github.pipeworx-io

Scan Dependency

scan_dependency
Read-onlyIdempotent

Composite "should I add this npm package to my project" check in ONE call — fans out across deps.dev (license + advisories + version history) and bundlephobia (gzipped/minified bundle size, dependency count, ESM/tree-shake support). Use whenever an agent asks "is X safe / popular / small" or "what does adding lodash cost me". Returns a summary block (is_latest, license, published_at, advisory_count, bundle_kb_min, bundle_kb_gz, dependency_count, has_esm, tree_shakeable), per-advisory detail, links, and a list of recent alternative versions. NPM ecosystem only in v1; PyPI / Maven / Cargo / Go fall under deps.dev:version directly. Partial failures degrade gracefully — bundlephobia's first measurement on a new version can take 5-30s; sources_failed will list it if it times out, the rest still returns.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
packageYesnpm package name. Scoped packages (e.g. "@types/node") are accepted.
versionNoSpecific version to check (e.g., "18.3.1"). Defaults to the latest published version when omitted.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already provide readOnlyHint, openWorldHint, idempotentHint, and destructiveHint. The description adds significant context: it fans out across external services, mentions specific partial failure scenarios (bundlephobia timeout, sources_failed), and lists the return fields. No contradictions with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is moderately long but well-structured: starts with the composite nature, then usage guidance, output summary, and limitations. Every sentence adds value, and it is front-loaded with the key purpose. Slightly verbose in the middle but still concise overall.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema, the description fully explains the return values (summary block, per-advisory detail, links, alternative versions) and covers partial failure behavior. For a tool with 2 parameters and high schema coverage, this is very complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% for both parameters (package and version), with clear descriptions in the schema. The description adds minimal extra value beyond what is in the schema (e.g., mentioning scoped packages, which is already in schema). Baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly defines the tool's purpose: a composite check for evaluating npm packages using deps.dev and bundlephobia. It specifies the resources checked (license, advisories, version history, bundle size, etc.) and differentiates from sibling tools which are unrelated (e.g., bet_research, scan_competitor_ai_presence).

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly states when to use this tool ('is X safe / popular / small', 'what does adding lodash cost me') and provides limitations: NPM ecosystem only in v1, with fallback guidance to deps.dev:version for other ecosystems. It also explains partial failure behavior and graceful degradation.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Mydisease toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

Multiple research/query entry points overlap heavily: ask_pipeworx and ask_pipeworx_beta are currently identical, ask_pipeworx_grounded and deep_research sit on the same routing core, and validate_claim/bet_research/entity_profile all wrap lookup-and-analyze behavior. The detailed descriptions help within specialized clusters, but the central ask_pipeworx family alone creates real selection ambiguity.

Naming Consistency3/5

All names are lower_snake_case and several families are consistent (ask_pipeworx_*, polymarket_*, remember/recall/forget), but the overall set mixes bare verbs, nouns, and verb_noun composites with no global pattern (disease, metadata, query, entity_profile, generate_llms_txt, validate_claim). It is readable but not predictable across the full 34-tool surface.

Tool Count2/5

34 tools is over the 25+ threshold and the set bundles several distinct domains—disease ontology, Pipeworx data access, prediction markets, AI visibility, npm scanning, memory, and subscriptions—into one server. Each subfamily may be justified, but the combined surface is heavy and makes tool selection harder than the underlying tasks require.

Completeness4/5

The disease domain has query/disease/metadata for search-and-fetch read coverage, and the broader research side has lookup, grounded verification, deep research, entity profiles, comparisons, subscriptions, and memory lifecycle tools. Minor gaps exist (no direct tool to fetch pipeworx:// citation URIs, no disease browsing/pagination), but these are workable rather than blocking.

Resources